Clinical Trial Update: REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erythropoietin after a large ST-segment elevation myocardial infarction aimed to reduce infarct expansion and ventricular remodeling; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Acute ST Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2017-05-09